Steris PLC (NYSE:STE) Director Jacqueline B. Kosecoff sold 3,609 shares of the company’s stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $132.22, for a total value of $477,181.98. The sale was disclosed in a filing with the SEC, which is available at this link.
STE opened at $133.35 on Friday. Steris PLC has a 1-year low of $99.14 and a 1-year high of $135.97. The company has a current ratio of 2.27, a quick ratio of 1.99 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $11.28 billion, a P/E ratio of 27.27 and a beta of 1.06.
Steris (NYSE:STE) last posted its quarterly earnings results on Monday, May 13th. The medical equipment provider reported $1.53 earnings per share for the quarter, beating analysts’ consensus estimates of $1.44 by $0.09. Steris had a return on equity of 13.34% and a net margin of 10.93%. The business had revenue of $768.00 million for the quarter, compared to analysts’ expectations of $738.87 million. During the same quarter in the prior year, the business earned $1.24 EPS. The firm’s revenue for the quarter was up 7.3% on a year-over-year basis. As a group, equities analysts expect that Steris PLC will post 5.36 earnings per share for the current year.
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Amundi Pioneer Asset Management Inc. grew its holdings in Steris by 6.9% in the 4th quarter. Amundi Pioneer Asset Management Inc. now owns 65,660 shares of the medical equipment provider’s stock valued at $7,016,000 after buying an additional 4,229 shares in the last quarter. Texas Permanent School Fund grew its holdings in Steris by 3.9% in the 1st quarter. Texas Permanent School Fund now owns 57,433 shares of the medical equipment provider’s stock valued at $7,353,000 after buying an additional 2,137 shares in the last quarter. Townsquare Capital LLC acquired a new position in Steris in the 4th quarter valued at $1,930,000. PNC Financial Services Group Inc. grew its holdings in Steris by 7.2% in the 4th quarter. PNC Financial Services Group Inc. now owns 27,470 shares of the medical equipment provider’s stock valued at $2,936,000 after buying an additional 1,845 shares in the last quarter. Finally, Norges Bank acquired a new position in Steris in the 4th quarter valued at $96,648,000. Institutional investors and hedge funds own 86.81% of the company’s stock.
A number of equities research analysts recently weighed in on the company. Stephens increased their price target on Steris from $135.00 to $150.00 and gave the company an “overweight” rating in a research note on Wednesday. KeyCorp increased their price target on Steris from $135.00 to $138.00 and gave the company an “overweight” rating in a research note on Wednesday. Zacks Investment Research upgraded Steris from a “hold” rating to a “buy” rating and set a $146.00 price target on the stock in a research note on Tuesday, April 30th. Finally, JMP Securities restated a “buy” rating and issued a $135.00 price target on shares of Steris in a research note on Thursday, February 14th. Five research analysts have rated the stock with a buy rating, The company presently has an average rating of “Buy” and a consensus price target of $145.20.
COPYRIGHT VIOLATION WARNING: “Insider Selling: Steris PLC (STE) Director Sells 3,609 Shares of Stock” was posted by Baseball Daily News and is the property of of Baseball Daily News. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this piece can be viewed at https://www.baseballdailydigest.com/news/2019/05/18/insider-selling-steris-plc-ste-director-sells-3609-shares-of-stock.html.
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.